Author： Al-Hujaily Ensaf M. Oldham Robyn A. A. Hari Parameswaran Medin Jeffrey A.
Publisher： MDPI
E-ISSN： 1422-0067|17|9|1506-1506
ISSN： 1422-0067
Source： International Journal of Molecular Sciences, Vol.17, Iss.9, 2016-09, pp. : 1506-1506
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Role of Immunotherapy in Multiple Myeloma
By Kocoglu Mehmet Badros Ashraf
Pharmaceuticals, Vol. 9, Iss. 1, 2016-01 ,pp. :
Access to resources
Recommend
Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. :
Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
By Merin Noah M. Kelly Kevin R.
Pharmaceuticals, Vol. 8, Iss. 1, 2014-12 ,pp. :